Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,005 public trials 1,217 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

NCT00600496

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +40 more
Locations: Research Site Detroit, Michigan, United States

Research Site Philadelphia, Pennsylvania, United States

Research Site Nashville, Tennessee, United States

Research Site Houston, Texas, United States

View Trial Details

Completed

Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

NCT05851378

Conditions: Adult Gliomas, Mixed, Glioma, Neoplasms, +6 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

NCT03336606

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cell Cancer, Squamous, +18 more
Locations: Providence Portland Medical Center Portland, Oregon, United States

View Trial Details

Completed

Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

NCT02860923

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniopharyngioma, +18 more
Locations: CHU d'Angers Angers, France

CHU de Brest Brest, France

CHU de Grenoble Grenoble, France

CHU de Lyon Lyon, France

View Trial Details

Completed

Multimodal Machine Learning Characterization of Solid Tumors

NCT04687969

Conditions: Adenocarcinoma, Adenocarcinoma of Prostate, Carcinoma, +33 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

NCT04253080

Conditions: Cutaneous Melanoma, Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, +11 more
Locations: Dermatology department Paris, Île-de-France Region, France

View Trial Details

Completed

A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype.

NCT03910660

Conditions: Carcinoma, Carcinoma, Small Cell, Genital Diseases, +17 more
Locations: University of California San Francisco (UCSF) San Francisco, California, United States

BioXcel Clinical Research Site Denver, Colorado, United States

Yale University New Haven, Connecticut, United States

Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

NCT07238322

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +13 more
Locations: University of California, San Francisco San Francisco, California, United States

University Hospital Essen Essen, Germany

Universityhospital Tuebingen Tübingen, Germany

The University Medical Center Utrecht Utrecht, Netherlands

View Trial Details

Completed

Evaluation of [18F]-FMISO for Non Operated Glioblastoma

NCT00906893

Conditions: Astrocytoma, Glioblastoma, Glioma, +11 more
Locations: CHU de Bordeaux - Hôpital Pellegrin Bordeaux, France

View Trial Details

Completed

Study of Pamiparib in Newly Diagnosed and rGBM

NCT04614909

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +9 more
Locations: St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions